As LLMs and diffusion models power more applications, their safety alignment becomes critical. Our research shows that even minimal downstream fine‑tuning can weaken safeguards, raising a key question ...
The London biotech will develop small-molecule therapies to target a pathway some cancer cells use to lengthen their life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results